Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.68 |
| ▸ | ABL1 | P00519 | 3/20 | 0.66 |
| ▸ | BCR | P11274 | 3/20 | 0.66 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | TOP1 | P11387 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4717327 | 0.91 | ABL1 (0.57) | KIF11ABL1BCRTRPV1FAAH | |
| SCHEMBL17694993 | 0.87 | MAPT (0.52) | KIF11ABL1BCR | |
| SCHEMBL17694984 | 0.87 | MAPT (0.52) | KIF11ABL1BCR | |
| SCHEMBL13410613 | 0.82 | KIF11 (1.00) | KIF11ABL1BCR | |
| SCHEMBL17694991 | 0.82 | ABL1 (0.50) | ABL1BCR | |
| SCHEMBL931294 | 0.82 | KIF11 (1.00) | KIF11ABL1BCR | |
| SCHEMBL17694989 | 0.82 | KIF11 (0.68) | KIF11ABL1BCRTOP1 | |
| SCHEMBL4659183 | 0.81 | KIF11 (0.61) | KIF11ABL1BCRTRPV1TOP1 | |
| SCHEMBL1011817 | 0.80 | ABL1 (0.51) | KIF11ABL1BCRTRPV1FAAH | |
| SCHEMBL12943121 | 0.80 | ABL1 (1.00) | ABL1BCRTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9932522-B2 | Electrochromic compound, electrochromic composition, display element, and dimming element | RICOH COMPANY, LTD. (JP) | 2018-04-03 | — | — | US | disclosed |
| US-9932522-B2 | Electrochromic compound, electrochromic composition, display element, and dimming element | RICOH COMPANY, LTD. (JP) | 2018-04-03 | — | — | US | disclosed |
| US-20170226413-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, DISPLAY ELEMENT, AND DIMMING ELEMENT | RICOH COMPANY, LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170226413-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, DISPLAY ELEMENT, AND DIMMING ELEMENT | RICOH COMPANY, LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226413-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, DISPLAY ELEMENT, AND DIMMING ELEMENT | EMC2, EMC1, KCNB2 | KIF11 2996/4885ABL1 1966/4885BCR 1311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.